The Clinical Development team at AffyImmune Therapeutics is responsible for designing, implementing, and managing clinical trials to evaluate the efficacy and safety of CAR T cell therapies against solid cancers. This includes trial planning, data management, regulatory compliance, and operational oversight to advance therapeutic candidates through various stages of clinical development.